Jefferies disagrees somewhat with some other analysts. The analyst highlights that gross margin development is significantly better than expected, while at the same time revenue is in line with estimates.
And as operating profit is “only” roughly in line with estimates, this points to increased research and development costs. And so, Q4 growth was 11% year-on-year!